Biomarker blood tests early disease detection: 15,000-patient study (NCT04241796), 94.2% sensitivity. FDA Breakthrough Device, $949 cost.
Blood-based diagnostics
Biomarker blood tests early disease detection: 15,000-patient study (NCT04241796), 94.2% sensitivity. FDA Breakthrough Device, $949 cost.